Addus HomeCare

Addus HomeCare Corp. engages in the provision of in-home personal care services. It operates through the following segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. The Hospice segment includes physical, emotional, and spiritual care for people who are terminally ill as well as for their families. The Home Health segment offers services that are primarily medical in nature to individuals who may require assistance during an illness or after surgery, and include skilled nursing and physical, occupational and speech therapy. The company was founded on July 27, 2006 and is headquartered in Frisco, TX.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Addus HomeCare reports robust Q4 earnings, eyes growth opportunities

Addus HomeCare delivered strong financial performance in Q4 2022, with revenue and earnings growth exceeding expectations.
The company's strategic strengths lie in its well-capitalized position, successful hiring initiatives, and positive outlook on value-based care contracts.
Challenges include hospice growth struggles and reimbursement issues, which are being actively addressed for sustainable growth.
Opportunities for Addus HomeCare include rate increases, acquisitions, sustained growth in personal care services, and optimizing the hospice business.

Addus HomeCare reports robust Q1 earnings amidst regulatory challenges

Addus HomeCare's Q1 2023 earnings call highlighted strong financial performance, operational strengths, concerns over proposed Medicaid payment rule, and growth opportunities in home health acquisitions. The company's strategic focus on financial management and workforce development positions it well for future growth and resilience in the evolving healthcare landscape.

Addus HomeCare reports revenue growth and strategic acquisitions in Q2

Addus HomeCare's Q2 2023 performance showcased revenue growth, strong financials, and strategic acquisitions.
While facing challenges from proposed rule changes and turnover rates, the company remains resilient.
Opportunities in value-based contracting, growth despite rate cuts, and caregiver engagement highlight future prospects.
Maintaining financial stability, Addus aims for growth through selective acquisitions and care strategy alignment.

Addus HomeCare posts robust Q3 results, eyes sustained growth

Addus HomeCare delivered a strong performance in Q3 2023, showcasing revenue growth, improved profitability, and strategic financial management.
While facing challenges such as margin impacts and revenue declines in certain segments, the company remains focused on sustaining margins and operational excellence.
Opportunities lie in continued growth in key service segments, market expansion, and leveraging positive market momentum for future success.

Addus HomeCare's Q4 2023 performance reflects strong revenue growth, improved margins, and a focus on debt reduction and strategic acquisitions.
The company's strengths lie in caregiver initiatives, revenue growth in key segments, and investments in value-based care programs and technology.
Challenges include union negotiations impacting margins, pandemic-related business disruptions, and the need for further operational efficiencies.
Opportunities include leveraging industry changes, expanding value-based care initiatives, and diversifying revenue streams through the Home Health business.

Addus HomeCare reports robust Q1 earnings, eyes growth opportunities

Addus HomeCare's strong financial performance in Q1 2024, coupled with strategic initiatives and confidence in overcoming challenges, positions the company for continued growth and success in the home-based care industry.

Addus HomeCare posts robust Q3 results, eyes strategic growth opportunities

Addus HomeCare delivered strong financial results in Q3 2024, driven by revenue growth, improved earnings, and strategic initiatives. The company's solid cash position, upcoming acquisition, and hiring momentum underscore its growth potential and operational strength.
While facing integration challenges and regulatory uncertainties, Addus HomeCare can capitalize on market opportunities like rate increases and funding to fuel its expansion and navigate industry challenges effectively.
Overall, Addus HomeCare's performance highlights its resilience, adaptability, and strategic focus on growth, positioning the company well for continued success in the evolving healthcare landscape.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Addus HomeCare Corp. engages in the provision of in-home personal care services. It operates through the following segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. The Hospice segment includes physical, emotional, and spiritual care for people who are terminally ill as well as related services for its families. The Home Health segment offers services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational, and speech therapy. The company was founded on July 27, 2006 and is headquartered in Frisco, TX.

JMP Securities initiated coverage on Addus HomeCare Corp ADUS, a provider of home-based personal care and clinical services.

As US Faces Shortage Of Expensive Skilled Clinicians, Home-Based Health Service Provider Addus HomeCare Is Well-Positioned To Grow: Analyst

Addus HomeCare (ADUS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Addus HomeCare (ADUS) Upgraded to Buy: Here's What You Should Know

Astrana Health Inc

Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Addus HomeCare (ADUS) and Astrana Health, Inc. (ASTH). But which of these two stocks presents investors with the better value opportunity right now?

ADUS vs. ASTH: Which Stock Is the Better Value Option?

FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced it has completed the acquisition of the personal care operations of Gentiva, which serve over 16,000 consumers per day in a seven-state service area of Arizona, Arkansas, California, Missouri, North Carolina, Tennessee and Texas. Addus funded the acquisition through a combination of cash on hand representing a portion of the proceeds of the Company's recent public offerin.

Addus HomeCare Completes Acquisition of Personal Care Operations of Gentiva

FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced that Dirk Allison, Chairman and Chief Executive Officer, Brad Bickham, President and Chief Operating Officer, and Brian Poff, Executive Vice President and Chief Financial Officer, will participate in the Stephens Annual Investment Conference, which takes place November 19 - 21 in Nashville, Tennessee. In connection with the conference, there will be a live broadcast and r.

Addus HomeCare to Participate in Stephens Annual Investment Conference

U.S. Physical Therapy

Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Addus HomeCare (ADUS) or U.S. Physical Therapy (USPH). But which of these two stocks presents investors with the better value opportunity right now?

ADUS vs. USPH: Which Stock Should Value Investors Buy Now?

Addus HomeCare Corporation (NASDAQ:ADUS ) Q3 2024 Earnings Conference Call November 5, 2024 9:00 AM ET Company Participants Dru Anderson - Senior Partner-FINN Partners Dirk Allison - Chairman & Chief Executive Officer Brian Poff - Chief Financial Officer Brad Bickham - President & Chief Operating Officer Conference Call Participants Brian Tanquilut - Jefferies Joanna Gajuk - Bank of America Tao Qiu - Macquarie Scott Fidel - Stephens Jared Haase - William Blair Matthew Gillmor - KeyBanc Andrew Mok - Barclays Ryan Langston - TD Cowen Operator Good day, and welcome to the Addus HomeCare's Third Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode.

Addus HomeCare Corporation (ADUS) Q3 2024 Earnings Call Transcript

Although the revenue and EPS for Addus HomeCare (ADUS) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Addus HomeCare (ADUS) Reports Q3 Earnings: What Key Metrics Have to Say

Addus HomeCare (ADUS) came out with quarterly earnings of $1.30 per share, beating the Zacks Consensus Estimate of $1.29 per share. This compares to earnings of $1.15 per share a year ago.

Addus HomeCare (ADUS) Q3 Earnings and Revenues Surpass Estimates

FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced its financial results for the third quarter and nine months ended September 30, 2024. Third Quarter 2024 Highlights: Net Service Revenues Increase 7.0% to $289.8 Million Net Income of $20.2 Million, or $1.10 per Diluted Share Adjusted Net Income per Diluted Share Increases 13.0% to $1.30 Adjusted EBITDA Increases 11.1% to $34.3 Million Cash Flow from Operations of $48.5 M.

Addus HomeCare Announces Third Quarter 2024 Financial Results

Addus HomeCare (ADUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Addus HomeCare (ADUS) Reports Next Week: Wall Street Expects Earnings Growth

Amedisys

Quest Diagnostics

Encompass Health

Dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, EHC, AMED and ADUS are well-poised to gain.

4 Stocks to Buy in an Evolving Outpatient Home Health Industry

FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the third quarter ended September 30, 2024, on Monday, November 4, 2024, after the market close. Addus HomeCare will host a conference call on Tuesday, November 5, 2024, at 9:00 a.m. Eastern Time. Joining the call from the Company will be Dirk Allison, Chairman and CEO, Brian Poff, Executive Vice President and CFO, and Brad Bickham, Presi.

Addus HomeCare Announces Third Quarter 2024 Earnings Release and Conference Call

All You Need to Know About Addus HomeCare (ADUS) Rating Upgrade to Buy

Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks offers value investors a better bang for their buck right now?

ADUS or USPH: Which Is the Better Value Stock Right Now?

Addus HomeCare Corporation (NASDAQ:ADUS ) Q2 2024 Earnings Conference Call August 6, 2024 9:00 AM ET Company Participants Dru Anderson – Senior Partner-FINN Partners Dirk Allison – Chairman and Chief Executive Officer Brian Poff – Chief Financial Officer Brad Bickham – President and Chief Operating Officer Conference Call Participants Tao Qiu – Macquarie Scott Fidel – Stephens Brian Tanquilut – Jefferies Jared Haase – William Blair Joanna Gajuk – Bank of America John Ransom – Raymond James Andrew Mok – Barclays Ben Hendrix – RBC Capital Markets Ryan Langston – Cowen Operator Good day, and welcome to the Addus HomeCare's Second Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode.

Addus HomeCare Corporation (ADUS) Q2 2024 Earnings Call Transcript

Atmos Energy

Halozyme Therapeutics

Leidos Hld

A company that is capable of generating earnings well above its interest expense can withstand financial hardship. HALO, LDOS, ATO & ADUS are sound enough to meet financial obligations.

4 Stocks That Flaunt an Impressive Interest Coverage Ratio

Although the revenue and EPS for Addus HomeCare (ADUS) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Addus HomeCare (ADUS) Reports Q2 Earnings: What Key Metrics Have to Say

Addus HomeCare (ADUS) came out with quarterly earnings of $1.35 per share, beating the Zacks Consensus Estimate of $1.20 per share. This compares to earnings of $1.07 per share a year ago.

Addus HomeCare (ADUS) Surpasses Q2 Earnings and Revenue Estimates

FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced its financial results for the second quarter and six months ended June 30, 2024. Second Quarter 2024 Highlights: Net Service Revenues Increased 10.4% to $286.9 Million Net Income of $18.1 Million, or $1.10 per Diluted Share Adjusted Net Income per Diluted Share Increased to $1.35 Adjusted EBITDA Increased 24.7% to $35.3 Million Cash Flow from Operations of $18.8 Million A.

Addus HomeCare Announces Second Quarter 2024 Financial Results

Chemed

Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and Chemed (CHE). But which of these two companies is the best option for those looking for undervalued stocks?

ADUS vs. CHE: Which Stock Is the Better Value Option?

DaVita

Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, EHC and ADUS are well-poised to gain.

4 Stocks to Watch From a Challenging Outpatient Home Health Industry

Addus HomeCare (ADUS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Addus HomeCare (ADUS) Earnings Expected to Grow: Should You Buy?

FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the second quarter ended June 30, 2024, on Monday, August 5, 2024, after the market close. Addus HomeCare will host a conference call on Tuesday, August 6, 2024, at 9:00 a.m. Eastern Time. Joining the call from the Company will be Dirk Allison, Chairman and CEO, Brian Poff, Executive Vice President and CFO, and Brad Bickham, President and.

Addus HomeCare Announces Second Quarter 2024 Earnings Release and Conference Call

FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS) (“Addus” or the “Company”), a provider of home care services, today announced the closing of an underwritten public offering of 1,725,000 shares of its common stock (“Common Stock”), including 225,000 shares of Common Stock sold pursuant to the exercise in full by the underwriters of their option to purchase additional shares, at a public offering price of $108.00 per share. The net proceeds to the Company from the offeri.

News for Addus HomeCare Stock (ADUS)